title: Microemulsion formulation increases cyclosporin bioavailability in cystic fibrosis.
authors.forename: G W
authors.initials: GW
authors.lastname: Mikhail
authors.forename: H
authors.initials: H
authors.lastname: Eadon
authors.forename: P
authors.initials: P
authors.lastname: Rogers
authors.forename: N
authors.initials: N
authors.lastname: Leaver
authors.forename: N R
authors.initials: NR
authors.lastname: Banner
authors.forename: A
authors.initials: A
authors.lastname: Khaghani
authors.forename: M H
authors.initials: MH
authors.lastname: Yacoub
mesh_terms: D000328:Adult; D001682:Biological Availability; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D003550:Cystic Fibrosis / Q000378:metabolism*; D004655:Emulsions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016040:Lung Transplantation; D008297:Male
chemical_list: D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine